SCP Medical Products, a platform company of Shore Capital Partners, has acquired Shippert Medical Technologies, a manufacturer of disposable medical and surgical products for ear, nose, throat, cosmetic, and plastic surgery applications.
Shippert products include cannulas and tubing, syringes, aspirators, splints, garments, wound drainage bulbs, and nasal, sinus, and ear packing systems. Shippert 
Medical was founded in 1978 by Sarah Shippert; CEO Dr. Ron Shippert – previously an otolaryngologist (an ear, nose and throat doctor) as well as a facial plastic and reconstructive surgeon – and Allison Therwhanger, the company’s CFO and COO. The Shippert family will retain an ownership stake in the company alongside Shore Capital. Mrs. Therwhanger will continue to serve in a leadership role as part of the SCP Medical Products platform. Shippert is headquartered south of Denver in Centennial, CO (www.shippertmedical.com).
“Our family believes Shore Capital will be an excellent partner to drive continued growth at the company,” said Mrs. Therwhanger. “We are pleased to become a part of the platform and look forward to building a leading specialty medical and surgical products business in the years to come.”
Shore Capital formed SCP Medical Products in February 2015 when it acquired Summit Medical, a designer and manufacturer of microsurgery products. In addition to its Instru-Safe instrument protection line for infection control and sterilization, Summit Medical manufactures ear, nose, and throat products and a variety of other surgical devices. The company is based in St. Paul (www.summitmedicalusa.com). Summit Medical was the second platform investment out of Shore Capital Partners Fund I, LP, a $112 million fund raised in May 2014.
Shore plans to leverage customer and distributor relationships across the two companies to drive organic growth and cross-selling opportunities.
“We are excited to add an exceptional company and management talent to our medical products platform,” said Don Pierce, a Partner at Shore Capital. “The Shippert family has built a highly-regarded business that complements Summit Medical very well. This investment epitomizes Shore’s strategy of partnering with strong owner-founder companies in one of our targeted sectors.”
Shore Capital Partners invests in lower middle market healthcare related companies that have $5 million to $50 million of revenue and $1 million to $5 million of EBITDA. Shore targets equity commitments of $10 million to $15 million per platform. Healthcare sectors of particular interest include behavioral health; healthcare staffing; infusion therapy; laboratory products & distribution; laboratory services; outpatient rehab therapy; urgent care; veterinary services; pharmaceutical services and contract research. Shore was founded in 2009 and is based in Chicago (www.shorecp.com).
Shore and the SCP Medical Products continue to pursue acquisitions of other service-oriented medical product companies serving hospitals and alternate site environments.
© 2015 PEPD • Private Equity’s Leading News Magazine • 10-20-15
